These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 24337478)
41. Progesterone levels in breast duct fluid. Rose DP; Tilton K; Lahti H; Wynder EL Eur J Cancer Clin Oncol; 1986 Jan; 22(1):111-3. PubMed ID: 3956554 [No Abstract] [Full Text] [Related]
42. Stress and the menstrual cycle: short- and long-term response to a five-day endotoxin challenge during the luteal phase in the rhesus monkey. Xiao E; Xia-Zhang L; Ferin M J Clin Endocrinol Metab; 1999 Feb; 84(2):623-6. PubMed ID: 10022427 [TBL] [Abstract][Full Text] [Related]
43. The corpus luteum of the primate menstrual cycle is capable of recovering from a transient withdrawal of pituitary gonadotropin support. Hutchison JS; Zeleznik AJ Endocrinology; 1985 Sep; 117(3):1043-9. PubMed ID: 3893990 [TBL] [Abstract][Full Text] [Related]
44. RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer. Lau YS; Danks L; Sun SG; Fox S; Sabokbar A; Harris A; Athanasou NA Breast Cancer Res Treat; 2007 Sep; 105(1):7-16. PubMed ID: 17151927 [TBL] [Abstract][Full Text] [Related]
45. A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma. Pujol P; Daures JP; Brouillet JP; Chang S; Rouanet P; Bringer J; Grenier J; Maudelonde T Cancer; 2001 May; 91(10):1854-61. PubMed ID: 11346866 [TBL] [Abstract][Full Text] [Related]
46. Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. Dougall WC Clin Cancer Res; 2012 Jan; 18(2):326-35. PubMed ID: 22031096 [TBL] [Abstract][Full Text] [Related]
47. Direct crosstalk between cancer and osteoblast lineage cells fuels metastatic growth in bone via auto-amplification of IL-6 and RANKL signaling pathways. Zheng Y; Chow SO; Boernert K; Basel D; Mikuscheva A; Kim S; Fong-Yee C; Trivedi T; Buttgereit F; Sutherland RL; Dunstan CR; Zhou H; Seibel MJ J Bone Miner Res; 2014 Sep; 29(9):1938-49. PubMed ID: 24676805 [TBL] [Abstract][Full Text] [Related]
49. Hypoxia induces RANK and RANKL expression by activating HIF-1α in breast cancer cells. Tang ZN; Zhang F; Tang P; Qi XW; Jiang J Biochem Biophys Res Commun; 2011 May; 408(3):411-6. PubMed ID: 21514280 [TBL] [Abstract][Full Text] [Related]
50. Long chain polyunsaturated fatty acids alter membrane-bound RANK-L expression and osteoprotegerin secretion by MC3T3-E1 osteoblast-like cells. Poulsen RC; Wolber FM; Moughan PJ; Kruger MC Prostaglandins Other Lipid Mediat; 2008 Feb; 85(1-2):42-8. PubMed ID: 18077200 [TBL] [Abstract][Full Text] [Related]
51. [Central regulation of body temperature by RANKL/RANK pathway]. Hanada R; Penninger JM Clin Calcium; 2011 Aug; 21(8):1201-8. PubMed ID: 21814026 [TBL] [Abstract][Full Text] [Related]
52. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition. Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS Menopause; 2009; 16(1):50-9. PubMed ID: 18978637 [TBL] [Abstract][Full Text] [Related]
53. RANKL-induced migration of MDA-MB-231 human breast cancer cells via Src and MAPK activation. Tang ZN; Zhang F; Tang P; Qi XW; Jiang J Oncol Rep; 2011 Nov; 26(5):1243-50. PubMed ID: 21725611 [TBL] [Abstract][Full Text] [Related]
54. Increased extracellular local levels of estradiol in normal breast in vivo during the luteal phase of the menstrual cycle. Dabrosin C J Endocrinol; 2005 Oct; 187(1):103-8. PubMed ID: 16214945 [TBL] [Abstract][Full Text] [Related]
55. Regulation of RANKL by biomechanical loading in fibrochondrocytes of meniscus. Deschner J; Wypasek E; Ferretti M; Rath B; Anghelina M; Agarwal S J Biomech; 2006; 39(10):1796-803. PubMed ID: 16038916 [TBL] [Abstract][Full Text] [Related]
56. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause. Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933 [TBL] [Abstract][Full Text] [Related]
57. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin. Fraser HM; Nestor JJ; Vickery BH Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885 [TBL] [Abstract][Full Text] [Related]
58. Hyaluronic acid prevents immunosuppressive drug-induced ovarian damage via up-regulating PGRMC1 expression. Zhao G; Yan G; Cheng J; Zhou X; Fang T; Sun H; Hou Y; Hu Y Sci Rep; 2015 Jan; 5():7647. PubMed ID: 25558795 [TBL] [Abstract][Full Text] [Related]
59. Modulation of Cytokine Production by the Dydrogesterone Metabolite Dihydrodydrogesterone. Raghupathy R; Al-Azemi M Am J Reprod Immunol; 2015 Nov; 74(5):419-26. PubMed ID: 26250154 [TBL] [Abstract][Full Text] [Related]
60. A molecular toolbox to study progesterone receptor signaling. Aarts MT; Wagner M; van der Wal T; van Boxtel AL; van Amerongen R J Mammary Gland Biol Neoplasia; 2023 Nov; 28(1):24. PubMed ID: 38019315 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]